platinum has been researched along with Carcinoma, Neuroendocrine in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (31.25) | 24.3611 |
| 2020's | 11 (68.75) | 2.80 |
| Authors | Studies |
|---|---|
| Economidou, SC; Fotopoulos, G; Vrontis, K | 1 |
| Abdel-Rahman, O; Koski, SL | 1 |
| Endoh, H; Fujita, A; Imai, H; Kaburagi, T; Kaira, K; Kanazawa, K; Kasai, T; Kiyoshima, M; Kotake, M; Matsuguma, H; Minato, K; Minemura, H; Nakamura, Y; Sugiyama, T; Suzuki, H; Yamada, Y | 1 |
| Baudin, E; Beaulaton, C; Blanchet, O; Chatelain, D; Do Cao, C; Ducreux, M; Faron, M; Hadoux, J; Hautefeuille, V; Hervieu, V; Hescot, S; Joubert Zakeyh, J; Kanaan, C; Laboureau, S; Leteurtre, E; Lombard-Bohas, C; Marchal, A; Perrier, M; Petorin, C; Rousselet, MC; Scoazec, JY; Tauveron, I; Walter, T | 1 |
| Ma, L; Wang, R; Wu, Z; Xia, H; Xiao, Y | 1 |
| Ida, K; Kanda, S; Kobayashi, T; Koizumi, T; Minagawa, T; Noguchi, T; Okumura, T; Sekiguchi, N; Tokumaru, S; Umemura, T | 1 |
| Adamo, V; Cantale, O; Castorina, L; Chillari, F; Colarossi, C; Esposito, F; Franchina, T; Giuffrida, D; Puliafito, I; Ricciardi, GRR; Russo, A; Sciacca, D; Vitale, MP | 1 |
| Kimura, T; Kurita, T; Miyoshi, AI; Ueda, Y; Yoshino, K | 1 |
| Ikeda, N; Kajiwara, N; Kudo, Y; Maehara, S; Matsubayashi, J; Minna, JD; Ohira, T; Otaki, Y; Shimada, Y | 1 |
| Asagi, A; Furukawa, M; Furuse, J; Hara, H; Hosokawa, A; Ikeda, M; Kojima, M; Kojima, Y; Mizuno, N; Murohisa, G; Ohkawa, S; Okusaka, T; Okuyama, H; Shioji, K; Yamanaka, T | 1 |
| Funasaka, C; Kageyama, A; Kanemasa, Y; Omuro, Y; Shimoyama, T | 1 |
| Hassan, U; Mozayani, B; Wong, NA | 1 |
| Brown, J; Burzawa, JK; Byers, LA; Coleman, RL; Frumovitz, M; Munsell, MF; Ramalingam, P | 1 |
| Chun, KC; Kim, DY; Kim, JH; Kim, YM; Kim, YT; Nam, JH | 1 |
| Abedallaa, N; Baey, C; Besse, B; de Montpreville, VT; Fabre, D; Guigay, J; Pechoux, CL; Pignon, JP; Planchard, D; Soria, JC; Tremblay, L | 1 |
| Couvelard, A; Gillet, A; Goujon, G; Hammel, P; Hentic, O; Lévy, P; Maire, F; Palazzo, M; Rebours, V; Ruszniewski, P; Zappa, M | 1 |
2 review(s) available for platinum and Carcinoma, Neuroendocrine
| Article | Year |
|---|---|
Clinical Analysis of Extrapulmonary Neuroendocrine Carcinoma: A Retrospective and Single Institution Experience.
Topics: Aged; Carcinoma, Neuroendocrine; Female; Humans; Male; Platinum; Prognosis; Retrospective Studies; Treatment Outcome | 2023 |
Recent Advances in the Management of Small Cell Carcinoma of the Uterine Cervix.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Carcinoma, Small Cell; Cervix Uteri; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Neoplasm Staging; Platinum; Rare Diseases; Small Cell Lung Carcinoma; Uterine Cervical Neoplasms | 2023 |
1 trial(s) available for platinum and Carcinoma, Neuroendocrine
| Article | Year |
|---|---|
A Phase II Trial of Everolimus in Patients with Advanced Pancreatic Neuroendocrine Carcinoma Refractory or Intolerant to Platinum-Containing Chemotherapy (NECTOR Trial).
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Neuroendocrine; Drug-Related Side Effects and Adverse Reactions; Everolimus; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Pancreatic Neoplasms; Platinum; Progression-Free Survival; Prospective Studies | 2020 |
13 other study(ies) available for platinum and Carcinoma, Neuroendocrine
| Article | Year |
|---|---|
Platinum Doublet plus Atezolizumab as First-line Treatment in Metastatic Large Cell Neuroendocrine Carcinoma: A Single Institution Experience.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Etoposide; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Platinum; Prospective Studies; Retrospective Studies; Small Cell Lung Carcinoma; Survival Analysis; Treatment Outcome | 2022 |
Cisplatin-Based versus Carboplatin-Based Chemotherapy for Extrapulmonary Neuroendocrine Carcinomas: A Real-World Study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Cisplatin; Etoposide; Humans; Lung Neoplasms; Platinum | 2022 |
Clinical Outcomes of Postoperative Adjuvant Chemotherapy for Surgically Resected High-Grade Pulmonary Neuroendocrine Carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Chemotherapy, Adjuvant; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Platinum; Retrospective Studies; Small Cell Lung Carcinoma | 2022 |
Second-line treatment and prognostic factors in neuroendocrine carcinoma: the RBNEC study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Etoposide; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Platinum; Prognosis; Retrospective Studies | 2022 |
Exploring a Better Adjuvant Treatment for Surgically Treated High-Grade Neuroendocrine Carcinoma of the Cervix.
Topics: Adult; Aged; Carcinoma, Neuroendocrine; Cervix Uteri; Chemotherapy, Adjuvant; Female; Humans; Hysterectomy; Middle Aged; Neoplasm Staging; Platinum; Pregnancy; Prognosis; Retrospective Studies; Uterine Cervical Neoplasms; Young Adult | 2022 |
Therapeutic efficacy of platinum/etoposide regimens in the treatment of advanced poorly differentiated neuroendocrine carcinomas of the lung: A retrospective analysis.
Topics: Carboplatin; Carcinoma, Neuroendocrine; Cisplatin; Etoposide; Humans; Lung; Lung Neoplasms; Neuroendocrine Tumors; Platinum; Retrospective Studies | 2023 |
Ubiquitin C-terminal hydrolase-L1 has prognostic relevance and is a therapeutic target for high-grade neuroendocrine lung cancers.
Topics: A549 Cells; Aged; Aged, 80 and over; Carcinoma, Neuroendocrine; Cell Line, Tumor; Cell Proliferation; Cell Survival; Enzyme Inhibitors; Extracellular Vesicles; Female; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Grading; Platinum; Prognosis; Small Cell Lung Carcinoma; Ubiquitin Thiolesterase; Up-Regulation | 2020 |
[Efficacy of Amrubicin Monotherapy for Patients with Extrapulmonary Neuroendocrine Carcinomas Refractory to Platinum-Based Chemotherapy].
Topics: Anthracyclines; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Female; Humans; Lung Neoplasms; Male; Middle Aged; Platinum; Retrospective Studies; Treatment Outcome | 2020 |
Primary combined neuroendocrine carcinoma (small-cell type) and squamous cell carcinoma of the colon.
Topics: Aged; Antineoplastic Agents, Phytogenic; Carcinoma, Neuroendocrine; Carcinoma, Squamous Cell; Colon; Colonic Neoplasms; Etoposide; Fatal Outcome; Humans; Male; Platinum; Point Mutation; Proto-Oncogene Proteins p21(ras); Tomography, X-Ray Computed | 2016 |
Combination therapy with topotecan, paclitaxel, and bevacizumab improves progression-free survival in recurrent small cell neuroendocrine carcinoma of the cervix.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Brain Neoplasms; Carcinoma, Neuroendocrine; Disease Progression; Disease-Free Survival; Female; Humans; Neoplasm Recurrence, Local; Paclitaxel; Platinum; Retrospective Studies; Survival Rate; Topotecan; Uterine Cervical Neoplasms; Young Adult | 2017 |
Neoadjuvant chemotherapy with paclitaxel plus platinum followed by radical surgery in early cervical cancer during pregnancy: three case reports.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cesarean Section; Female; Humans; Hysterectomy; Magnetic Resonance Imaging; Neoadjuvant Therapy; Paclitaxel; Platinum; Pregnancy; Pregnancy Complications, Neoplastic; Uterine Cervical Neoplasms | 2010 |
Effect of chemotherapy in patients with resected small-cell or large-cell neuroendocrine carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lung Neoplasms; Lymph Nodes; Male; Methotrexate; Middle Aged; Neoplasm Staging; Perioperative Care; Platinum; Pneumonectomy; Prognosis; Retrospective Studies; Small Cell Lung Carcinoma; Survival Rate | 2012 |
FOLFIRI regimen: an effective second-line chemotherapy after failure of etoposide-platinum combination in patients with neuroendocrine carcinomas grade 3.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Camptothecin; Carcinoma, Neuroendocrine; Disease-Free Survival; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Male; Middle Aged; Neoplasm Grading; Pancreatic Neoplasms; Pelvic Neoplasms; Platinum; Treatment Outcome | 2012 |